Home
|Insights
|“Pharmaceutical legislation & regulatory developments,” and “The case of Dimethyl Fumarate: where is it heading to?,” 19th Legal Affairs Conference, Medicines for Europe, Brussels

PDF Link

“Pharmaceutical legislation & regulatory developments,” and “The case of Dimethyl Fumarate: where is it heading to?,” 19th Legal Affairs Conference, Medicines for Europe, Brussels

Speaking Engagement | 06.23.25

Contacts

Kristof Roox
Partner
- Brussels
  - D | +32.2.282.1843
a3Jvb3hAY3Jvd2VsbC5jb20=

Insights

Speaking Engagement | 10.15.25

“CMS ramps up scrutiny on improper payments: What plans need to know,” Becker’s Hospital Review

Speaking Engagement | 10.01.25
"SBA Mentor-Protégé Program and Small Business Joint Venturing – Recap of Key Rules and Regs," Crowell & Moring Small Business Webinar Series.
Speaking Engagement | 09.30.25
"Developments in Consumer Protection, UDAP Laws, and Private Enforcement Models," Nineteenth Annual Judicial Symposium on Civil Justice Issues
Speaking Engagement | 09.30.25
"The Evolving Requirements Tied to Supply Chain Mapping Due Diligence and Anti-Forced Labor", States General International Trade Compliance Conference (2nd Edition)

View All Insights

Subscribe

to the latest insights from our team